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Abstract
Objective
To study whether the circadian variation of plasminogen-activator-inhibitor-1 (PAI-1) levels,
with high morning levels, is associated with poor outcome of children with meningococcal
sepsis presenting in the morning hours.
Design
Retrospective analysis of prospectively collected clinical and laboratory data.
Setting
Single center study at Erasmus MC-Sophia Children’s Hospital, Rotterdam, the
Netherlands.
Subjects
184 patients aged 3 weeks to 18 years with meningococcal sepsis. In 36 of these children,
PAI-1 levels at admission to the PICU were measured in plasma by ELISA.
Interventions
None.
Measurements and main results
Circadian variation was studied by dividing one day in blocks of 6 hours. Patients admitted
between 6:00 am and 12:00 am had increased illness severity scores and higher PAI-1
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levels (n = 9, median 6912 ng/mL, IQR 5808–15600) compared to patients admitted at night
(P = 0.019, n = 9, median 3546 ng/mL, IQR 1668–6118) or in the afternoon (P = 0.007,
n = 7, median 4224 ng/mL, IQR 1804–5790). In 184 patients, analysis of circadian variation
in relation to outcome showed more deaths, amputations and need for skin grafts in patients
admitted to the PICU between 6:00 am and 12:00 am than patients admitted during the rest
of the day (P = 0.009).
Conclusions
Circadian variation of PAI-1 levels is present in children with meningococcal sepsis and is
associated with illness severity, with a peak level in the morning. Whether circadian variation
is an independent risk factor for morbidity and mortality in meningococcal sepsis needs to
be explored in future studies.
Introduction
Meningococcal endotoxins and the subsequent inflammatory host response induce excessive
coagulation and downregulation of fibrinolysis in meningococcal sepsis. Hence, the delicate
balance between coagulation and anti-coagulation shifts towards thrombosis and widespread
deposition of fibrin throughout the microcirculation, with thromboembolism contributing to
the need to amputate extremities, multiple organ dysfunction, and eventually death. [1]
In meningococcal sepsis, plasminogen-activator-inhibitor-1 (PAI-1) levels are increased
and result in inhibited fibrinolysis and impaired anticoagulant mechanism, since PAI-1 neu-
tralizes activated protein C [2], leading to severe disseminated intravascular coagulation
(DIC). [3, 4] The PAI1 4G/5G polymorphism is associated with PAI-1 levels and with out-
come. The highest risk for mortality is present in 4G/4G homozygous individuals, who pro-
duce the highest levels of PAI-1. [3]
The genotype is one of the multiple mechanisms which influences PAI-1 levels. Physiologi-
cally, levels are also subject to circadian variation, causing a PAI-1 peak in the morning. [5, 6]
In meningococcal sepsis, clustering of fatal cases in the morning hours has been reported
repeatedly. These findings are generally interpreted as the result of delayed detection of symp-
toms and subsequent health care seeking behavior, as signs of severe illness may easily be over-
looked in the night or early morning hours. [7, 8] We hypothesize that the circadian variation
of PAI-1, with high morning levels, is associated with excess mortality of cases presenting in
the morning hours, possibly due to aggravation of multiple organ failure secondary to more
severe DIC.
Here, we aim to study the circadian variation of PAI-1 levels in children with meningococ-
cal sepsis in relation to outcome.
Materials and Methods
We retrospectively analyzed clinical and laboratory data of a cohort of 184 patients aged 3
weeks to 18 years with meningococcal sepsis, who were enrolled in Rotterdam based meningo-
coccal studies from 1988 to 2005. [3, 9] All patients fulfilled internationally agreed criteria for
sepsis. [10] Meningococcal sepsis was diagnosed clinically (n = 28) and/or by positive culture
or PCR from sterile sites (n = 156). In 36 of these children, PAI-1 levels at admission to the
PICU were measured in plasma by ELISA as described before. [3, 9] Blood samples were taken
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on admission to the PICU, processed on ice and stored at -80 degree Celsius until analysis.
[11] All studies were approved by the ethical committee of Erasmus MC, and written informed
consent was obtained from parents or legal guardians.
Circadian variation was studied by dividing one day in blocks of 6 hours. Illness severity
was indicated by the probability of death based on the BEP score (P (death BEP)) [12], DIC
score [13], and Pediatric Risk of Mortality (PRISM) [14]. Quantitative variables are presented
either as mean (±SD) when normally distributed or as median (IQR). For normally distributed
variables, t-tests were used to compare two groups, while for non-normal variables the Mann-
Whitney U test was used. To compare PAI-1 levels and illness severity between four time peri-
ods, we used a One-Way ANOVA when the depending variable was normally distributed and
the Kruskal-Wallis test when the depending variable was non-normally distributed. The corre-
lation between PAI-1 and illness severity was studied by Pearson’s (for normally distributed
variables) or Spearman’s (for non-normally distributed variables) correlation. Chi squared
tests or Fisher’s exact tests-in case of small sample size-were used to assess the association
between two categorical variables. Data were analyzed using SPSS version 21.
Results
Baseline characteristics of the total cohort of 184 patients and the 36 children in whom PAI-1
levels were measured (PAI-1 cohort) are presented in Table 1. Both groups had similar demo-
graphics, but illness severity in the PAI-1 cohort was higher as reflected by higher P (death
BEP) and higher DIC score at admission.
Patients admitted between 6:00 am and 12:00 am had higher PAI-1 levels (n = 9, median
6912 ng/mL, IQR 5808–15600) than patients admitted at night (P = 0.019, n = 9, median 3546
ng/mL, IQR 1668–6118) or in the afternoon (P = 0.007, n = 7, median 4224 ng/mL, IQR 1804–
5790). (Fig 1A) The distribution of PAI1 4G/5G genotype (P = 0.71) and allele frequency
(P = 0.72) did not differ between four time periods.
In concordance with the variation in PAI-1 levels, patients admitted between 6:00 am and
12:00 am had an increased illness severity based on the BEP score (median P (death BEP) 0.26,
IQR 0.16–0.44) than patients admitted at night (P = 0.009, median P (death BEP) 0.05, IQR
0.02–0.15), patients admitted in the afternoon (P = 0.001, median P (death BEP) 0.05, IQR
0.04–0.05), or patients admitted in the evening (P = 0.037, median P (death BEP) 0.10, IQR
0.04–0.24). Illness severity reflected by the DIC score did not differ between four time periods
(P = 0.13). Moreover, illness severity correlated to PAI-1 levels (correlation between BEP score
and PAI-1: r = 0.77, n = 36, P<0.001; correlation between DIC score and PAI-1: r = 0.67,
n = 34, P<0.001).
The morning PAI-1 peak level and the morning peak in illness severity in 36 children was
not associated with poor outcome, as defined by deaths, amputations and/or need for skin
grafts (P = 0.24). To increase power, we analyzed circadian variation in the total group of 184
Table 1. Baseline characteristics of all patients (n = 184) and the PAI-1 cohort (n = 36).
All patients (n = 184) PAI-1 cohort (n = 36) P
Age (median, IQR) 3y (18m-8y) 2y (12m-9y) ns
Sex (% male) 59% 56% ns
P (death BEP) (median, IQR) 0.05 (0.03–0.12) 0.09 (0.04–0.23) <0.01
DIC score at admission (mean, ±SD) 4.7 (1.9) 5.6 (2.0) <0.05
Abbreviations: P (death BEP) = Probability of death based on the BEP score, DIC = Disseminated
intravascular coagulation, IQR = Interquartile range, SD = Standard deviation, m = month(s), y = year(s).
doi:10.1371/journal.pone.0167004.t001
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patients, and found a worse outcome in patients admitted to the PICU between 6:00 am and
12:00 am than patients admitted during the rest of the day (P = 0.009). Of the 184 patients, 49
patients were admitted between 6:00 am and 12:00 am, of whom 12 patients (7%) eventually
had a poor outcome (6 deaths, 4 amputations and 2 skin grafts). This in contrast to 135
patients who were admitted during the rest of the day, of whom 13 patients had a poor out-
come (00-06h: 2 deaths and 1 amputation (2%); 12-18h: 2 amputations (1%); 18-00h: 4 deaths,
3 amputations and 1 skin graft (4%)). (Fig 1B) Patients admitted between 6:00 am and 12:00
am showed a trend for higher PRISM, BEP score, and DIC score compared to patients admit-
ted during the rest of the day. (PRISM 21.3 (±11.0) vs 16.1 (±10.0), P = 0.06; P (death BEP)
0.06 (IQR 0.02–0.20) vs 0.04 (IQR 0.03–0.10), P = 0.16; DIC 5.2 (±1.6) vs 4.5 (±2.1), P = 0.09)
Data underlying the findings from this study can be found in S1 File.
Discussion
This study provides insight into the circadian variation of PAI-1 levels in children with menin-
gococcal sepsis, and shows a significant PAI-1 peak level in the morning. Because the distribu-
tion of PAI1 4G/5G genotype and allele frequency, known to be associated with PAI-1 levels
[3], did not differ between time periods, it is likely that PAI-1 levels in meningococcal sepsis
are associated with circadian variation. However, numbers are limited and we cannot exclude
other factors also influencing PAI-1 levels in these patients. [15]
Illness severity is one of the main factors associated with PAI-1 levels and multiple studies
have associated high PAI-1 levels with increased illness severity. [3, 16–19] Also in our cohort,
we found a strong correlation between PAI-1 levels and illness severity. Thus, given the corre-
lation between PAI-1 and illness severity, PAI-1 could either be a marker for illness severity or
a contributor to illness severity. [20] Future studies should specify the role of circadian varia-
tion of PAI-1 levels in meningococcal sepsis severity.
Our results show that patients admitted to the PICU in the morning have a worse outcome
than patients admitted during the rest of the day. These results of outcome are in line with a
retrospective epidemiological study from Western Norway, where meningococcal sepsis
patients, both adults and children, hospitalized between 7:00 am and 11:00 am had a poorer
prognosis than those admitted during other hours of the day. [8] Although multiple factors
Fig 1. Time of admission to PICU in relation to plasminogen-activator-inhibitor-1 levels and outcome.
(A) Patients admitted between 6:00 am and 12:00 am had higher plasminogen-activator-inhibitor-1 levels than
patients admitted at night (P = 0.019) or in the afternoon (P = 0.007). (PAI-1 level on y-axis in logarithmic
scale. Bar within box represents median, box represents Q1-Q3, whiskers represent 1.5*IQR, dots are
outliers) (B) Outcome in patients admitted to the PICU between 6:00 am and 12:00 am was worse than
patients admitted during the rest of the day (P = 0.009). (Error bars represent 95% CI)
doi:10.1371/journal.pone.0167004.g001
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could have influenced increased morning severity, especially a possible delay in detection of
symptoms during the night and early morning, in our opinion, morning PAI-1 peak levels
might have contributed to this effect.
Scheer and Shea [5] reported a true endogenous circadian rhythm in circulating PAI-1 inde-
pendent of behavioral and environmental factors. Absolute values of healthy adults had a peak-
to-trough amplitude of 1.24 ng/mL, corresponding with an increase from trough to peak of
124%. In our cohort, the lowest median PAI-1 value of a time period was 3546 ng/mL, which
increased to a peak value of 6912 ng/mL in the morning, corresponding with an increase of
95%. The extremely high PAI-1 level in meningococcal sepsis compared to patients with men-
ingitis alone or healthy controls has been described before. [3] However, this is the first report
describing that circadian variation of PAI-1 levels—and associated circadian variation of illness
severity—is also present in meningococcal sepsis patients with extremely high PAI-1 levels.
In conclusion, our data demonstrate an association between circadian variation of PAI-1
levels and illness severity in pediatric meningococcal sepsis patients, with a significant peak
level in the morning. Future study in a larger cohort of patients should focus on the question
whether the morning PAI-1 peak is an independent risk factor for morbidity and mortality in
meningococcal sepsis.
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